Quick Answer
Prune Gut Microbiota Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 7 Menopause is associated with a rapid decline in bone mineral density (BMD) and deterioration in bone quality, thus compromising bone strength and predisposing postmenopausal women to increased risk for osteoporosis and fragility fractures.
Key Takeaways
- 011 2 3 4 7 Menopause is associated with a rapid decline in bone mineral density (BMD) and deterioration in bone quality, thus compromising bone strength and predisposing postmenopausal women to increased risk for osteoporosis and fragility fractures. [Simpson Abigayle M. R. (2024)]
- 02Calcium and vitamin D supplementation is considered a standard nutritional therapy for managing fracture risk (,). [Simpson Abigayle M. R. (2024)]
- 03There is increasing interest in leveraging select foods and bioactive food components for ameliorating bone loss and reducing fracture risk. [Simpson Abigayle M. R. (2024)]
- 04Dietary interventions are aimed at prevention of bone loss or as co-therapies to osteoporosis treatment. [Simpson Abigayle M. R. (2024)]
The current Migaku evidence database contains 2 reusable source documents for Prune Gut Microbiota Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- 1 2 3 4 7 Menopause is associated with a rapid decline in bone mineral density (BMD) and deterioration in bone quality, thus compromising bone strength and predisposing postmenopausal women to increased risk for osteoporosis and fragility fractures. [Simpson Abigayle M. R. (2024); evidence level 4]
- Calcium and vitamin D supplementation is considered a standard nutritional therapy for managing fracture risk (,). [Simpson Abigayle M. R. (2024); evidence level 4]
- There is increasing interest in leveraging select foods and bioactive food components for ameliorating bone loss and reducing fracture risk. [Simpson Abigayle M. R. (2024); evidence level 4]
- Dietary interventions are aimed at prevention of bone loss or as co-therapies to osteoporosis treatment. [Simpson Abigayle M. R. (2024); evidence level 4]
- Along with the striking effect on bone health, GC treatment and 25% DP supplementation led to drastic shifts in gut microbiota composition and several specific changes are strongly associated with bone health. [Chargo NJ (2024); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources